{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:57:18Z","timestamp":1789711038595,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1053\/gast.2003.50141","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T17:58:00Z","timestamp":1122659880000},"page":"961-971","source":"Crossref","is-referenced-by-count":217,"title":["Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease"],"prefix":"10.1053","volume":"124","author":[{"given":"Catalina","family":"Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Juarranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Leceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa P.","family":"Gomariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/gast.2003.50141_bib1","first-page":"479","article-title":"The extraintestinal manifestations of inflammatory bowel disease","author":"Retsky","year":"1995"},{"key":"10.1053\/gast.2003.50141_bib2","first-page":"31","article-title":"The epidemiology of idiopathic inflammatory bowel disease","author":"Calkins","year":"1995"},{"key":"10.1053\/gast.2003.50141_bib3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1096\/fj.99-0885hyp","article-title":"Does the failure to acquire helminthic parasites predispose to Crohn's disease?","volume":"14","author":"Elliot","year":"2000","journal-title":"FASEB J"},{"key":"10.1053\/gast.2003.50141_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","article-title":"Antibodies to IL-12 abrogate established experimental colitis in mice","volume":"183","author":"Neurath","year":"1995","journal-title":"J Exp Med"},{"key":"10.1053\/gast.2003.50141_bib5","first-page":"12S","article-title":"Optimizing therapy for inflammatory bowel disease","volume":"92","author":"Robinson","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2003.50141_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0016-5085(98)70420-2","article-title":"Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients","volume":"114","author":"Lapidus","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2003.50141_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2036.16.s4.8.x","article-title":"A critical approach to new forms of treatment of Crohn's disease and ulcerative colitis","volume":"4","author":"Seegers","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2003.50141_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/gast.2002.33426","article-title":"Biologic therapy of inflammatory disease","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2003.50141_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of colonic inflammation and ulceration in the rat colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2003.50141_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","article-title":"Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease","volume":"157","author":"Fuss","year":"1996","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0602-567","article-title":"The role of Th1\/Th2 polarization in mucosal immunity","volume":"8","author":"Neurath","year":"2002","journal-title":"Nat Med"},{"key":"10.1053\/gast.2003.50141_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomariz","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1053\/gast.2003.50141_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF\u03b1 and IL-6","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease","volume":"7","author":"Delgado","year":"2001","journal-title":"Nat Med"},{"key":"10.1053\/gast.2003.50141_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","article-title":"Cellular and extracellular myeloperoxidase in pyogenic inflammation","volume":"78","author":"Bradley","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1053\/gast.2003.50141_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/PL00000223","article-title":"Tissue cytokine and chemokine expression in inflammatory bowel disease","volume":"50","author":"McCormack","year":"2001","journal-title":"Inflamm Res"},{"key":"10.1053\/gast.2003.50141_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2567.2002.01309.x","article-title":"Role of chemokines and chemokine receptors in the gastrointestinal tract","volume":"105","author":"Ajuebor","year":"2002","journal-title":"Immunology"},{"key":"10.1053\/gast.2003.50141_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1007023611478","article-title":"Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in rat","volume":"25","author":"Sun","year":"2001","journal-title":"Inflammation"},{"key":"10.1053\/gast.2003.50141_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1053\/gast.2003.50141_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-135-4-200108210-00013","article-title":"Migration of T cells in vivo: molecular mechanisms and clinical implications","volume":"135","author":"Westermann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.2003.50141_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000067180","article-title":"Pituitary adenylate-cyclase-activating polypeptide expression in the immune system","volume":"10","author":"Abad","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1053\/gast.2003.50141_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01296290","article-title":"Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases","volume":"4","author":"Koch","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2003.50141_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0016-5085(92)90762-N","article-title":"Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease","volume":"102","author":"Kubota","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2003.50141_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-5728(99)00023-5","article-title":"VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFN\u03b3 synthesis by T cells","volume":"96","author":"Delgado","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1053\/gast.2003.50141_bib25","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.162.4.2358","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit endotoxin-induced TNF-a production by macrophages: in vitro and in vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jlb.63.5.591","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide modulate endotoxin-induced IL-6 production in murine peritoneal macrophages","volume":"63","author":"Martinez","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1053\/gast.2003.50141_bib27","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-\u03baB and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib28","first-page":"90","article-title":"Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis","volume":"44","author":"Niderau","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/gast.2003.50141_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J Exp Med"},{"key":"10.1053\/gast.2003.50141_bib30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.155.3.1184","article-title":"A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion","volume":"155","author":"Xu","year":"1995","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4049\/jimmunol.156.3.1189","article-title":"Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells","volume":"156","author":"Preciado-Patt","year":"1996","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-3083.1998.00394.x","article-title":"Human serum amyloid A has cytokine-like properties","volume":"48","author":"Patel","year":"1998","journal-title":"Scand J Immunol"},{"key":"10.1053\/gast.2003.50141_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/bbrc.1998.9911","article-title":"Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway","volume":"254","author":"Olsson","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/gast.2003.50141_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02443485","article-title":"Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-\u03b1 by human T-lymphocytes","volume":"5","author":"Preciado-Patt","year":"1998","journal-title":"Lett Peptide Sci"},{"key":"10.1053\/gast.2003.50141_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1053\/gast.2003.50141_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0167-5699(00)01590-5","volume":"21","author":"D'Ambrosio","year":"2000","journal-title":"Immunol Today"},{"key":"10.1053\/gast.2003.50141_bib37","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.163.8.4213","article-title":"VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression","volume":"163","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0140-6736(00)02871-3","article-title":"Mechanisms in failure of infliximab for Crohn's disease","volume":"356","author":"Nikolaus","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/gast.2003.50141_bib39","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.164.9.4878","article-title":"IL-6 is required for the development of Th1 cell-mediated murine colitis","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/gast.2003.50141_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"10.1053\/gast.2003.50141_bib41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0016-5085(99)70392-6","article-title":"Anti-interleukin 12 treatment regulates apoptosis of Th1 cells in experimental colitis in mice","volume":"117","author":"Fuss","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2003.50141_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin-10 in the function of regulatory T-cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J Exp Med"},{"key":"10.1053\/gast.2003.50141_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/019262339902700124","article-title":"The role of IL-10 in inflammatory bowel disease: \u201cof mice and men\u201d","volume":"27","author":"Leach","year":"1999","journal-title":"Toxicol Pathol"},{"key":"10.1053\/gast.2003.50141_bib44","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1084\/jem.183.6.2605","article-title":"Experimental granulomatous colitis in mice is abrogated by induction of TGF-\u03b2 mediated oral tolerance","volume":"183","author":"Neurath","year":"1996","journal-title":"J Exp Med"},{"key":"10.1053\/gast.2003.50141_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0196-9781(94)00192-8","article-title":"Homologous regulation of vasoactive intestinal peptide (VIP) on rat peritoneal macrophages","volume":"16","author":"Pozo","year":"1995","journal-title":"Peptides"},{"key":"10.1053\/gast.2003.50141_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(73)91947-8","article-title":"Vasoactive intestinal polypeptide and watery-diarrhea syndrome","volume":"2","author":"Bloom","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/gast.2003.50141_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(00)00229-7","article-title":"Vasoactive intestinal peptide: cardiovascular effects","volume":"49","author":"Henning","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1053\/gast.2003.50141_bib48","first-page":"545","article-title":"Aviptadil (Senatek)","volume":"4","author":"Keijzers","year":"2001","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508503000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508503000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:56:34Z","timestamp":1683150994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508503000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0016508503000556"],"URL":"https:\/\/doi.org\/10.1053\/gast.2003.50141","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}